
Arshad M. Khanani MD, MA, FASRS
Advertisement
Articles by Arshad M. Khanani MD, MA, FASRS


Dr Khanani shared his first-time results talk during an AAO specialty day

Arshad M. Khanani, MD, MA, FASRS, highlights the fluid resolution with faricimab and the need for loading doses, especially in high-needs switch patients with nAMD or DME.

Arshad M. Khanani, MD, MA, FASRS, discusses rapid improvement with faricimab in several anatomic parameters in treatment-naïve and previously treated patients with nAMD and DME in the TRUCKEE and TAHOE studies.
Advertisement
Latest Updated Articles
AAO 2025: Arshad M. Khanani, MD, MA, FASRS, shares GA results from the GATHER2 extension trialPublished: October 17th 2025 | Updated:
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
FLORetina 2025: EU-ROP Registry bridges borders for real-world insight
2
FLORetina 2025: New horizons in research and risk management for ROP
3
FLORetina 2025: Antithrombotic use examined in wet AMD submacular hemorrhage
4
FLORetina 2025: Navigating antithrombotic therapy in wet AMD
5

